BE847541A - Nouveaux ethers phenoliques disbstitues de 3-amino-2-hydroxypropane, leur procede de preparation et medicament les contenant - Google Patents

Nouveaux ethers phenoliques disbstitues de 3-amino-2-hydroxypropane, leur procede de preparation et medicament les contenant

Info

Publication number
BE847541A
BE847541A BE171708A BE171708A BE847541A BE 847541 A BE847541 A BE 847541A BE 171708 A BE171708 A BE 171708A BE 171708 A BE171708 A BE 171708A BE 847541 A BE847541 A BE 847541A
Authority
BE
Belgium
Prior art keywords
disbstituted
hydroxypropane
amino
preparation process
product containing
Prior art date
Application number
BE171708A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE847541A publication Critical patent/BE847541A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/36Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE171708A 1975-10-23 1976-10-22 Nouveaux ethers phenoliques disbstitues de 3-amino-2-hydroxypropane, leur procede de preparation et medicament les contenant BE847541A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752547524 DE2547524A1 (de) 1975-10-23 1975-10-23 Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
BE847541A true BE847541A (fr) 1977-04-22

Family

ID=5959934

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171708A BE847541A (fr) 1975-10-23 1976-10-22 Nouveaux ethers phenoliques disbstitues de 3-amino-2-hydroxypropane, leur procede de preparation et medicament les contenant

Country Status (29)

Country Link
US (1) US4110472A (fr)
JP (1) JPS5935387B2 (fr)
AT (2) AT344682B (fr)
AU (1) AU502167B2 (fr)
BE (1) BE847541A (fr)
BG (2) BG31796A3 (fr)
CA (1) CA1085417A (fr)
CH (2) CH623562A5 (fr)
CS (2) CS191344B2 (fr)
DD (1) DD128555A5 (fr)
DE (1) DE2547524A1 (fr)
DK (1) DK480376A (fr)
ES (1) ES452616A1 (fr)
FI (1) FI67075C (fr)
FR (1) FR2328458A1 (fr)
GB (1) GB1497500A (fr)
GR (1) GR61598B (fr)
HU (1) HU174097B (fr)
IE (1) IE43745B1 (fr)
IL (1) IL50732A (fr)
LU (1) LU76057A1 (fr)
NL (1) NL7611683A (fr)
NO (1) NO143844C (fr)
PL (2) PL110002B1 (fr)
PT (1) PT65737B (fr)
RO (1) RO76883A (fr)
SE (1) SE432926B (fr)
SU (2) SU639443A3 (fr)
ZA (1) ZA766303B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223395B (it) * 1987-12-01 1990-09-19 Simes Composti ad attivita' cardiovascolare
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
BRPI0810063A2 (pt) * 2007-04-20 2014-10-14 Acucela Inc Composto, composição farmacêutica, e, métodos para modular fluxo de cromóforo em um ciclo retinóide, para tratar uma doença ou distúrbio oftálmico em um indivíduo, para inibir adaptação ao escuro em uma célula fotorreceptora de bastão da retina, para inibir regeneração de rodopsina em uma célula fotoreceptora de bastão da retina, para reduzir isquemia em um olho de um indivíduo, para inibir neovascularização na retina de um olho de um indivíduo, e para inibir degeneração de uma célula da retina em uma retina
FR3030514A1 (fr) * 2014-12-18 2016-06-24 Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) Dimeres polyaromatiques
EP3144289A1 (fr) * 2015-09-16 2017-03-22 Evonik Technochemie GmbH Composés à terminaison [(2-ethoxy-5-trans-1-propen-1-yl) -phenoxyl]
CN110035745B (zh) * 2016-10-05 2022-04-29 匹兹堡大学联邦系统高等教育 小分子ampk活化剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758583A (en) * 1971-01-21 1973-09-11 Syntex Corp 2-(2-hydroxy-3-aminopropyl-1-yloxy)-1,6-dilfuoro-and-1,6-methano-{8 10{9 annulenes and the salts thereof

Also Published As

Publication number Publication date
PL110007B1 (en) 1980-06-30
RO76883A (fr) 1981-08-30
AT345792B (de) 1978-10-10
FR2328458B1 (fr) 1979-03-02
FR2328458A1 (fr) 1977-05-20
CS191344B2 (en) 1979-06-29
AT344682B (de) 1978-08-10
AU1879776A (en) 1978-04-27
GR61598B (en) 1978-12-02
NO763442L (fr) 1977-04-26
FI67075B (fi) 1984-09-28
FI67075C (fi) 1985-01-10
ES452616A1 (es) 1978-01-16
GB1497500A (en) 1978-01-12
SE7611686L (sv) 1977-04-24
ATA606377A (de) 1978-02-15
JPS5251352A (en) 1977-04-25
ATA784476A (de) 1977-12-15
PT65737A (en) 1976-11-01
PL110002B1 (en) 1980-06-30
CS191322B2 (en) 1979-06-29
LU76057A1 (fr) 1977-05-31
HU174097B (hu) 1979-11-28
ZA766303B (en) 1977-09-28
AU502167B2 (en) 1979-07-12
IE43745L (en) 1977-04-23
DE2547524A1 (de) 1977-04-28
SU664559A3 (ru) 1979-05-25
SU639443A3 (ru) 1978-12-25
IL50732A0 (en) 1976-12-31
SE432926B (sv) 1984-04-30
DD128555A5 (de) 1977-11-23
IE43745B1 (en) 1981-05-20
NO143844B (no) 1981-01-12
NL7611683A (nl) 1977-04-26
FI763010A (fr) 1977-04-24
JPS5935387B2 (ja) 1984-08-28
PL193206A1 (pl) 1979-03-12
BG27732A3 (en) 1979-12-12
CA1085417A (fr) 1980-09-09
BG31796A3 (en) 1982-03-15
DK480376A (da) 1977-04-24
CH623562A5 (fr) 1981-06-15
US4110472A (en) 1978-08-29
IL50732A (en) 1979-12-30
NO143844C (no) 1981-04-22
CH630058A5 (de) 1982-05-28
PT65737B (en) 1978-04-20

Similar Documents

Publication Publication Date Title
BE860726A (fr) Nouveaux aryl-acylamides n-(2-aminocy-cloaliphatiques), leur procede de preparation et medicament les contenant
BE860727A (fr) Nouveaux benzamides trans-n-(2-aminocycloaliphatiques), leur procede de preparation et medicament les contenant
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
BE845179A (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
BE865015A (fr) Pseudotrisaccharides, leur procede de preparation et medicament les contenant
FR2307543A1 (fr) Nouveaux amides peptidiques, leur procede de preparation et medicament les contenant
BE868943A (fr) Nouveaux 3-indolyl-tertiobutylaminopropanols, leur procede de production et medicament les contenant
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
FR2303538A1 (fr) Nouveaux ethers cycliques, leur procede de preparation et medicament les contenant
BE847541A (fr) Nouveaux ethers phenoliques disbstitues de 3-amino-2-hydroxypropane, leur procede de preparation et medicament les contenant
BE861697A (fr) Nouveaux antibiotiques polycycliques, leur procede de preparation et medicament les contenant
FR2346354A1 (fr) Nouvelles as-triazinobenzodiazepine-1-ones, leur procede de preparation et medicament les contenant
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
FR2316946A1 (fr) Nouvelles penicillines, leur procede de preparation et medicament les contenant
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
BE859949A (fr) Nouveaux derives thiazoliques leur procede de preparation et medicament antherminthique les contenant
BE802496A (fr) Nouveaux 2-amino-4h-pyrannes, leur procede de preparation et medicament les contenant
BE849047A (fr) Nouvelles 2-(p-naphtyloxy)-ethylpyrazolones, leur procede de preparation et medicament les contenant
BE827119A (fr) Nouveaux 1-arylucaciles, leur procede de preparation et medicament les contenant
FR2348924A1 (fr) Nouvelles carbonylpiperazinylquinazolines azoliques,leur procede de preparation et medicament les contenant
FR2346352A1 (fr) Nouvelles triazinobenzodiazepines, leur procede de preparation et medicament les contenant
FR2297845A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
FR2311544A1 (fr) Nouvelles pyridoquinoleines, leur procede de preparation et medicament les contenant
BE862273A (fr) Nouveaux antibiotiques du type methoxy-beta-lactame, leur procede de preparation et medicament les contenant
BE856771A (fr) Nouveaux di-n-oxydes de quinoxaline, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAYER A.G.

Effective date: 19851031